Triptorelin Market
- 2026 年市場規模
- USD 673.1 Mn
- 2033 年預估規模
- USD 960.3 Mn
- 年複合成長率 CAGR
- 5.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Triptorelin Market, By Drug Type (Triptorelin pamoate, Triptorelin acetate, Triptorelin embonate), By Application (Prostate Cancer, Radical Prostatectomy, Endometriosis, Salivary Gland Cancer, Central Precocious Puberty), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Triptorelin is a peptide formulation for injection that was developed mainly for the treatment of advanced metastatic prostate cancer. Furthermore, other indications developed subsequently include the treatment of uterine fibroids (a benign tumor of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilization). Other modalities of triptorelin such as triptorelin acetate, triptorelin pamoate and triptorelin embonate are also used for prostate cancer treatment.
Market Dynamics
Triptorelin market is expected to witness lucrative growth opportunities during forecast period, owing to increasing incidence of prostate cancer and salivary gland cancer and increasing prevalence of central precocious puberty among the young patients below age eight and nine years, worldwide. For instance, according to National Organization for Rare Disorders (NORD), 2016 data findings, Central Precocious Puberty (CPP), accounted for 1 to 5 in 10,000 children with a female to male ratio of about 20:1, in U.S.
In March 2017, Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, in coordination with fourteen other European regulatory agencies approved a new indication of Decapeptyl (triptorelin). According to these new indication, Decapeptyl (triptorelin) will be used as adjuvant treatment in combination with tamoxifen or aromatase inhibitor for endocrine-responsive early-stage breast cancer in women at high-risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy. This would enhance the revenue for growth for triptorelin market, during forecast period.
Furthermore, higher efficacy and tolerability of triptorelin in suppression of gonadotropin secretion in prostate cancer and precocious puberty is increasing adoption of triptorelin in the market.
Key features of the study
• This report provides in-depth analysis of triptorelin market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global triptorelin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Ipsen, Bachem, Ferring Pharmaceuticals Pvt Ltd., Chengdu Tiantaishan pharmaceutical Co., Ltd., Tecnofarma, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.), Debiopharm Group, and Arbor Pharmaceuticals, LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global triptorelin market report caters to various stakeholders in this industry including investors, suppliers, triptorelin based product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the triptorelin market.
Market Segmentation
• By Drug Type (Revenue, USD Mn, 2021-2033)
o Triptorelin pamoate
o Triptorelin acetate
o Triptorelin embonate.
• By Application (Revenue, USD Mn, 2021-2033)
o Prostate Cancer
o Radical Prostatectomy
o Endometriosis
o Salivary Gland Cancer
o Central Precocious Puberty
• By Distribution Channel (Revenue, USD Mn, 2021-2033)
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Ipsen
o Bachem
o Ferring Pharmaceuticals Pvt Ltd.
o Chengdu Tiantaishan pharmaceutical Co., Ltd.,
o Tecnofarma
o Reddy’s Laboratories Ltd.
o Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
o Debiopharm Group
o Arbor Pharmaceuticals, LLC.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Regulatory Scenario
o Market Trends
o Epidemiology
o New Product Approvals/Launch
o Mergers/ Acquisition
o Strategic Collaborations
o PEST Analysis
4. Global Triptorelin Market, By Drug Type, 2021 - 2033 (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Triptorelin pamoate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Triptorelin acetate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Triptorelin embonate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
5. Global Triptorelin Market, By Application, 2021 - 2033 (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Prostate Cancer
Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
o Radical Prostatectomy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Endometriosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Salivary Gland Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Central Precocious Puberty
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
6. Global Triptorelin Market, By Distribution Channel, 2021 - 2033 (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
o Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
7. Global Triptorelin Market, By Regions, 2021 - 2033 (US$ Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022 - 2033
o North America
Market Size and Forecast, By Drug Type, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Million)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Drug Type, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Drug Type, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Drug Type, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Million)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Size and Forecast, By Drug Type, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Million)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Ipsen
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Bachem
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Ferring Pharmaceuticals Pvt Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Chengdu Tiantaishan pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Tecnofarma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Dr. Reddy’s Laboratories Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Debiopharm Group
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Arbor Pharmaceuticals, LLC
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
o Analyst Views
9. Section
o References
o Analyst Views
o Research Methodology
o About Us and Sales Contact
Browse 26 market data tables and 21 figures on Triptorelin Market - Global forecast to 2033”.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們